Dhanusha Sabanathan retweetet
English
Dhanusha Sabanathan
85 posts
Dhanusha Sabanathan retweetet
CSO Webinar announcement! 📣 Register today!
Join Dr. Anuradha Vasista and Dr. Deme Karikios as we talk about discussing prognosis with patients living with advanced cancers.
The webinar will take place on Zoom on March 19th at 7:00 pm Australian Eastern Daylight Time (8:00 am GMT / 9:00 am CET / 11:00 am CAT / 1:30 pm IST / 5:00 pm JST).
Link to register: queensu.zoom.us/meeting/regist…
English
Dhanusha Sabanathan retweetet
Congratulations to Wei Yen and team for latest important advance in ctDNA in neoadjuvant immunotherapy in stage III melanoma 👏👏url.au.m.mimecastprotect.com/s/86RdCBNqgBC7… @MelanomaAus @MQMedicalSchool
English
Dhanusha Sabanathan retweetet
Congratulations to Dr Walid Zwieky and Dr Su Win core medical oncology trainees from the NeMMO training network for presenting their research at #MOGA24 🙌 @DKarikios @DSabanathan @DrJohnJPark @NBMLHD @Macquarie_Uni @MOGA_ORG
English
Dhanusha Sabanathan retweetet
Come and join us at an information evening 6pm Thursday August 8 if you're interested in Medical Oncology training and would like to join the Nepean-Macquarie-Mater-Orange network.
🍕 and 🥤provided!
Info below:
English
Dhanusha Sabanathan retweetet
Come and work with us at @MquniCTU! Multiple Medical Oncology Fellow positions available for 2025 👇 @DSabanathan @DrJohnJPark @HowardGurney linkedin.com/posts/andrew-p…
English
Dhanusha Sabanathan retweetet
‼️📝New @JCO_ASCO publication co-authored by @DrJohnJPark👨🏻⚕️🇦🇺 Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a HER2–Directed Antibody-Drug Conjugate, in HER2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I trial @MquniCTU ➡️ ascopubs.org/doi/10.1200/JC… 🧵1/X
English
Dhanusha Sabanathan retweetet
Median pooled OS over 5 years for MBC on first line ET and CDK4/6 - @AOParsonson
@anuradhavasista
@brownjlauren @BelindaKiely @Macquarie_Uni
oncodaily.com/insight/87165.…
#Cancer #Cancerawareness #Cancersupport #Cancersupportcommunity #Oncology #Oncodaily #Chemotherapy #Breastcancer
English
Dhanusha Sabanathan retweetet
A team effort with @anuradhavasista @brownjlauren @BelindaKiely et al 📝 🙌 simple multiples of the median OS from RCTs can be used to estimate and communicate #prognosis for patients with advanced breast cancer starting endocrine therapy doi.org/10.1111/ajco.1… 🧵 1/X
English
Dhanusha Sabanathan retweetet
Kudos to Dr. Clifton et al for putting together this SABCS23 abstract on the real world toxicity of KN522. 16 sites, 577 pts with TNBC. The KN522 regimen led to a pCR rate of 54%, at the cost of 40% early discontinuations, 11% hospitalization, 54% irAEs, including permanent ones.
English
Dhanusha Sabanathan retweetet
Honored to present the #OP1250/#palazestrant data at #ESMO23. Encouraging activity in heavily pretreated ER+ pts including >7 mo PFS regardless of ESR1 mut status in 2/3L pts corresponding to EMERALD eligible subset (with elacestrant, median PFS 2.8 mo in all/3.8 mo in ESR1 mut)
Erika Hamilton, MD, FASCO@ErikaHamilton9
#OP1250 (#palazestrant) oral CERAN presented by Dr. Lin. - 42% pts 3 lines or greater - CBR 40% in all comers, CBR 52% among ESR1m - mPFS 4.6 mo in all comers, 5.6 mo among ESR1m - among just 2/3L pts like EMERALD, PFS around 7 months #ESMO23 #bcsm
English
Such a privilege to have @oncology_bg at Nepean Cancer Care Centre @NBMLHD! Such an inspiration
Dr Deme Karikios@DKarikios
Lucky to have @oncology_bg presenting at Nepean Hospital today on Pitfalls of Interpretation of Clinical Trials. Looking forward to hearing him talk at the @MOGA_ORG ASM #moga23 @NBMLHD
English
Dhanusha Sabanathan retweetet
Come and work with us at the Macquarie University trials unit @MquniCTU Lots of trials, especially in GU, breast and phase 1. Part-time also considered. @DSabanathan @AOParsonson @AlisonZhangMBBS @mcrumbaker1
Medical Oncology Group of Australia (MOGA)@MOGA_ORG
Job Opportunity: MQ Health seeks a Medical Oncology Fellow - Clinical Trials Unit. Full-time. Location: Sydney. Applications Close 26 July. More info: moga.org.au/oncology-posit…
English
Dhanusha Sabanathan retweetet
Interesting to see junior oncologists recommending significantly more chemo vs. senior oncologists
⬆️ experience apparently comes with a trend toward de-escalation of treatment
Luca Licata, MD@LLicata88
📢(1/5) Just published in @Nature_NPJ Breast Cancer our study assessing how Oncotype DX results impact physicians' confidence and concordance in adjuvant chemotherapy recommendations for early breast cancer patients. Read more: 📌rdcu.be/dd3nv 👇👇👇
English
Australia is ready!!! #ASCO2023 post ASCO soccer tournament. @cdanicas @HowardGurney @DrJohnJPark @DKarikios @AdnanNagrial @MattCarlino @amenzies9 @mstaniasimon @siobhanonei11
English
Dhanusha Sabanathan retweetet
English
I enjoyed so much working with @DKarikios! He didn’t take no for an answer, and charged on! He is a critical part of what made todays event a success!
Australia is lucky to have this passionate clinician and @MOGA_ORG leader!
#fintox @COSAoncology #leadership #teamwork
English
Dhanusha Sabanathan retweetet
Today 27 women (half of our 2023 Sydney mentees!) from diverse organisations across the health & medical research ecosystem came together at @Macquarie_Uni for their mentee intial workshop 🌟 discussing leadership, inclusion, networks & goals for the 6m ahead 🙌 #WomenInSTEMM
English